Patient treatment pathway analysis for venom allergies

  • Increased customer/patient satisfaction and conversion rate

  • Gained a better understanding of stakeholders’ and patients’ behaviour along the pathway

  • Compiled key parameters to focus on when launching products to mitigate venom allergies

  • Understand the patient treatment pathway for allergic reactions to bee/wasp/hornet stings
  • Understand a patient’s experience with healthcare providers during treatment of allergy
  • Understand a patient’s preference for and experience with venom immunotherapy (VIT)
  • Conducted detailed primary research of c.300 patients diagnosed with allergies to bee/wasp/hornet stings
    • Respondent selection: respondents from six European countries diagnosed medically with venom allergies
    • Diagnosis and treatment: in-depth analysis of diagnosis of allergic reactions and treatment modalities
    • Experience with VIT: information on familiarity with VIT treatment, adoption and completion of treatment
  • Analysed the large amount of data the research generated to gain meaningful insight on a patient’s behaviour
    • Demographic analysis: analysed patient preferences and behaviour by demographic and geography Stakeholder
    • Stakeholder analysis: analysed the level of interaction between patients and stakeholders at different stages of treatment and assessed the importance of each stakeholder
    • VIT treatment analysis: analysed a patient’s preference for VIT over other treatment and studied how they were made aware of such treatment
  • Acuity Knowledge Partners provided research and analysis support to formulate actionable insights
  • Provided a comprehensive assessment of demographics, stakeholders and patient behaviour
  • Highlighted the importance of each parameter along the VIT treatment pathway
  • Identified level of penetration and stakeholders’ knowledge of current treatments
  • Helped client ascertain which stakeholders or regions to target and focus resources on
  • Highlighted patients’ pain points along the treatment pathway, helping the client improve their product/s and service
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of

Identified opportunities for expansion and plausible revenue streams

Identified potential geographies and activation levers from competitors

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Benchmarked therapeutic areas with high clinical and market potential

Developed potential market scenarios based on client needs

Assessing viability of entering the NSCLC market
What we are proud of

Evaluated unmet needs to identify potential entry points

Conducted a deep-dive study of key assets and key players

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

Optimised vendor-associated costs across geographies

Identified billing arrangements across law firms

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

Analysed potential for entry into the GCC pharmaceutical market

Assessed possible market drivers and barriers to entry

Product launch strategy for European biopharmaceutical company
What we are proud of

Identified geographical concentration of demand

Designed optimal distribution channel configuration

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

Assessed the target market size, key competitors and current pricing range

Enabled the client to take informed decisions thereby increasing market penetration